PCSK9 and atherosclerosis: Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a major role in cholesterol metabolism and atherosclerosis by modulating the circulating levels of low-density lipoprotein (LDL), the key molecule that transports cholesterol in the blood [1,2].